At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
defibrillatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Public Access Defibrillation (PAD) Community Trial
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Feb 10, 2000·Updated Apr 14, 2016
In Brief
A Phase 3 clinical trial evaluating defibrillator for Arrhythmia and 5 related conditions. Completed.
Detailed Summary
To measure survival to hospital discharge of patients with out-of-hospital cardiac arrest in community units (e.g., apartment or office buildings, gated communities, sports venues, senior centers, shopping malls) served by trained non-medical responders using automated external defibrillators (AEDs), an approach called Public Access Defibrillation, compared to units receiving the traditional optimum community standard of care (i.e., rescuers trained to recognize a cardiac emergency, call 911, and initiate CPR).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Heart Arrest, Heart Diseases, Myocardial Infarction, Ventricular Fibrillation, Death, Sudden, Cardiac
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1999
First PostedFeb 2000
Study CompletionFeb 2004
TodayJul 2026
First PostedFeb 10, 2000
Enrollment StartSep 1, 1999
Study CompletionFeb 1, 2004
TodayJul 2, 2026
Posted 26.4 years ago
Interventions
defibrillatordevice